Warby Parker Inc. Net Change in Cash
Warby Parker Inc. (WRBY) reported Net Change in Cash of $6.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-06
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $1.89M, a 82.70% decline year-over-year.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $10.91M, a 212.69% increase year-over-year.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $3.49M.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$4.32M.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $32.20M, a 13.60% decline from fiscal 2024.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $37.27M, a 348.51% increase from fiscal 2023.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $8.31M.
- Warby Parker Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$47.83M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.32M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $1.89M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $32.20M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $26.20M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $32.22M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $10.91M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $37.27M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $34.14M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $21.06M 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | $3.49M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $8.31M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $7.38M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $4.07M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$4.32M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$47.83M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$58.53M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | -$44.81M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$26.09M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$57.67M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$47.85M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$53.41M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$18.06M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $258.66M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $243.97M 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | -$94.36M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |